• Skip to main content
  • Skip to primary sidebar
Transfusion News
  • About Us
  • Topics
    • Adverse Events (non-infectious)
    • Blood Donation
    • Cell Therapy
    • Coagulation & Plasma Transfusion
    • Platelet Transfusion
    • Policy and Guidelines
    • Quality Control and Regulatory
    • RBC Transfusion
    • Serology/Genotyping
    • Special Transfusion Situations
    • Transfusion Transmitted Infections
  • Continuing Education
  • Archives
  • Podcasts
  • Question of the Day
  • Search
  • Subscribe to Email Alerts
  • Follow us on
  • Search
  • Subscribe to Email Alerts

Low Threat of an Ebola Outbreak in High-Resource Countries

August 22, 2014

Tx_news_22_augustAnthony Fauci, Director of the National Institute of Allergy and Infectious Diseases in the United States, wrote a perspective for The New England Journal of Medicine summarizing the Ebola virus disease (EVD) outbreak in West Africa.

He reassured the public that the threat of an EVD outbreak in high-resource countries is low. The EVD outbreak which started in the West African countries of Guinea, Liberia, and Sierra Leone has now spread to Nigeria, claiming more than 1000 lives.  The Ebola Filoviridae virus is a zoonotic pathogen with reservoirs potentially in apes and fruit bats. EVD transmission in humans occurs from direct contact with body fluids from an infected animal or person.  Transfusion-transmitted EVD infections have not been documented. With time and careful public health practices in Africa, the outbreak will eventually be controlled.  The AABB has a fact sheet available on EVD.

References
1. Fauci AS. Ebola – Underscoring the Global Disparities in Health Care Resources. N Engl J Med 2014.
2. AABB Resource.  Ebola Virus.  Available from:  http://www.aabb.org/tm/eid/Documents/72s.pdf  Accessed August 19, 2014

 

Filed Under

  • News
  • Transfusion Transmitted Infections

Recommended

  • Randomized Trial Demonstrates that Hydroxyurea is Not Effective as Transfusion in Preventing Strokes

  • WHO May Add Blood to Model List of Essential Medicines

  • Weak HLA Antibody Levels Not Associated with Platelet Refractoriness

Show Comments

Comments on this article are closed.

Get the latest news. Subscribe to our mailing list. Sign Up

Primary Sidebar

Latest News

  • RBCs with Reduced Deformability are Removed from Circulation

  • Array-based, comprehensive genotyping for erythroid, platelet, neutrophil and leukocyte antigens

  • Acute Normovolemic Hemodilution Does Not Reduce RBC Transfusions

  • Blood Donation Teams—a Novel Strategy to Support Novice Donors

    Question of the Day

    Copyright © 2025 John Wiley & Sons, Inc. All Rights Reserved.
    Privacy Policy

    Association for the Advancement of Blood and Biotherapies Wiley